DNA methylation screening of primary prostate tumors identifies SRD5A2 and CYP11A1 as candidate markers for assessing risk of biochemical recurrence

The Prostate
Aaron M HorningTim Hui-Ming Huang

Abstract

Altered DNA methylation in CpG islands of gene promoters has been implicated in prostate cancer (PCa) progression and can be used to predict disease outcome. In this study, we determine whether methylation changes of androgen biosynthesis pathway (ABP)-related genes in patients' plasma cell-free DNA (cfDNA) can serve as prognostic markers for biochemical recurrence (BCR). Methyl-binding domain capture sequencing (MBDCap-seq) was used to identify differentially methylated regions (DMRs) in primary tumors of patients who subsequently developed BCR or not, respectively. Methylation pyrosequencing of candidate loci was validated in cfDNA samples of 86 PCa patients taken at and/or post-radical prostatectomy (RP) using univariate and multivariate prediction analyses. Putative DMRs in 13 of 30 ABP-related genes were found between tumors of BCR (n = 12) versus no evidence of disease (NED) (n = 15). In silico analysis of The Cancer Genome Atlas data confirmed increased DNA methylation of two loci-SRD5A2 and CYP11A1, which also correlated with their decreased expression, in tumors with subsequent BCR development. Their aberrant cfDNA methylation was also associated with detectable levels of PSA taken after patients' post-RP. Multivariate...Continue Reading

References

Mar 21, 2001·Human Molecular Genetics·S B BaylinJ G Herman
Nov 6, 2001·Clinica Chimica Acta; International Journal of Clinical Chemistry·M StrounP Anker
May 28, 2003·Microscopy Research and Technique·Marion B Sewer, Michael R Waterman
Jan 21, 2004·Nature Reviews. Cancer·Andrew P Feinberg, Benjamin Tycko
Apr 7, 2004·The Journal of Clinical Investigation·Gennadi V GlinskyWilliam L Gerald
Dec 31, 2004·Cancer Control : Journal of the Moffitt Cancer Center·Michael Diaz, Stephen G Patterson
Jun 3, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Patrick J BastianWilliam G Nelson
Jul 7, 2005·JAMA : the Journal of the American Medical Association·Ian M ThompsonCharles A Coltman
Nov 17, 2006·Annals of the New York Academy of Sciences·R Swaminathan, Asif N Butt
Apr 18, 2007·The Journal of Urology·Susan CottrellGunter Weiss
May 13, 2008·Best Practice & Research. Clinical Endocrinology & Metabolism·Van Luu-TheFernand Labrie
Mar 10, 2010·Laboratory Investigation; a Journal of Technical Methods and Pathology·Ken J KronBharati Bapat
Jan 6, 2011·International Journal of Cancer. Journal International Du Cancer·Liyang LiuBharati Bapat
Jul 29, 2011·Proceedings of the National Academy of Sciences of the United States of America·Kai-Hsiung ChangNima Sharifi
Oct 4, 2011·Nature Genetics·Florian LienertDirk Schübeler
May 17, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Saswati MahapatraKrishna Vanaja Donkena
Aug 10, 2012·Epigenetics : Official Journal of the DNA Methylation Society·Ekaterina Olkhov-MitselBharati Bapat
Dec 28, 2012·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Pâmela Oliveira DelgadoFernando Luiz Affonso Fonseca
Jan 16, 2013·Current Treatment Options in Oncology·Laurence Klotz
Jan 25, 2013·Science Translational Medicine·Martin J AryeeSrinivasan Yegnasubramanian
Jun 14, 2013·Nature Reviews. Cancer·Winston Timp, Andrew P Feinberg
Feb 21, 2014·Science Translational Medicine·Chetan BettegowdaLuis A Diaz
Apr 9, 2014·BMC Cancer·Anthony E RizzardiStephen C Schmechel
Sep 16, 2014·Genome Biology·Giulia Siravegna, Alberto Bardelli
Sep 23, 2014·International Journal of Molecular Sciences·Siri H StrandKarina D Sorensen
Dec 3, 2014·PloS One·Naoko Sueoka-AraganeShinya Kimura

❮ Previous
Next ❯

Citations

Jan 15, 2016·Endocrine-related Cancer·Kristina WartonGoli Samimi
Sep 22, 2016·Clinical Epigenetics·Milan S GeybelsJanet L Stanford
Apr 16, 2017·Molecular Cancer·Ashley Di MeoGeorge M Yousef
Oct 21, 2020·Cancers·Dilys LamRuth Pidsley
Jul 1, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Shanshan ZhaoJanet L Stanford
Jan 26, 2020·General and Comparative Endocrinology·Julie Robitaille, Valerie S Langlois

❮ Previous
Next ❯

Related Concepts

Related Feeds

Actin-binding Proteins

Actin-binding proteins are a component of the actin cytoskeleton that play essential roles in cellular functions such as regulation of actin polymerization, maintenance of cell polarity, gene expression regulation, cell motility and many more functions. Discover the latest research on actin-binding proteins here.